Malignant Epithelioid Hemangioendothelioma, also known as epithelioid hemangioendothelioma, malignant, is related to epithelioid hemangioendothelioma and hemangioendothelioma. An important gene associated with Malignant Epithelioid Hemangioendothelioma is CAMTA1 (Calmodulin Binding Transcription Activator 1), and among its related pathways/superpathways is Smith-Magenis and Potocki-Lupski syndrome copy number variation. Affiliated tissues include endothelial and liver, and related phenotype is growth/size/body region.